Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gynefam Oro is a multivitamin and multimineral dietary supplement developed and marketed in Italy by Effik Italia (a subsidiary of Italfarmaco). It is specifically formulated to meet the increased nutritional requirements of women during pregnancy and breastfeeding, or to address insufficient dietary intake of essential vitamins and minerals. The product is presented as an orodispersible oral powder (bustine orosolubili) that dissolves directly in the mouth without water, making it particularly suitable for pregnant women experiencing nausea or difficulty swallowing tablets. Its comprehensive formulation includes folic acid (folate), iron fumarate, magnesium oxide, magnesium bisglycinate, B-group vitamins (B1, B2, B6, B12), sodium fluoride, calcium carbonate, zinc oxide, potassium iodide, nicotinamide, cholecalciferol (vitamin D3), biotin, and sodium selenite. It is gluten-free and supports general maternal health, fetal development, and nervous system function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gynefam Oro.